start portlet menu bar end portlet menu bar

Vaccination with PRV vaccine (AUSKIPRA® GN; Bartha k61 strain), reduced virus shedding when challenge against Chinese PRV variant (AH02 strain)

Home Knowledge Vaccination with PRV vaccine (AUSKIPRA® GN; Bartha k61 strain), reduced virus shedding when challenge against Chinese PRV variant (AH02 strain)

Vaccination with PRV vaccine (AUSKIPRA® GN; Bartha k61 strain), reduced virus shedding when challenge against Chinese PRV variant (AH02 strain)

Since 2011 several pseudorabies (PR) outbreaks have damaged Chinese swine industry. In this study MLV PRV vaccine (AUSKIPRA® GN reconstituted in A3 diluent, HIPRA) was challenged with new PRV variant (AH02 strain) isolated from a farm suffering from acute outbreak of PRV in China. Virus shedding on nasal swabs was studied in two independent experiments.

Download this article

746 KB

About this article

Appeared in

APVS Congress, 2015

Authors

Zeng, R.; Wang, J.; Torrents, D.; Martinez, C.; Pedrazuela, R.

Summary

AUSKIPRA® GN vaccine reduce PRV shedding after AH02 strain challenge. Therefore, AUSKIPRA® GN can be a useful tool to control PRV infection in Chinese farms.

Related services

HIPRA Diagnos

Related products

AUSKIPRA® GN

AUSKIPRA® BK

Related publications

Survey of pseudorabies sero-prevalence in 11 provinces of China Retrospective study on the prevalence of Aujeszky's disease in major pig producing provinces in the Philippines (2006-2010) Pseudorabies (Aujeszky’s virus disease) vaccination protocols in China

Share this on

start portlet menu bar

Vaccination with PRV vaccine (AUSKIPRA® GN; Bartha k61 strain), reduced virus shedding when challenge against Chinese PRV variant (AH02 strain)

Display portlet menu
end portlet menu bar

See also

Publications

Safety comparative study of two reproductive vaccines administered during lactation

06-03-2018
Disease Summaries

Edema disease

03-11-2017
News

HIPRA begins its journey into Taiwan with the SENG range

06-04-2018